FDA In Brief: FDA to Hold Advisory Committee Meeting to Discuss Pfizer-BioNTech’s Application for COVID-19 Booster

FDA announced a virtual VRBPAC meeting to discuss the Pfizer-BioNTech supplemental application for a third (“booster”) dose of Comirnaty (COVID-19 Vaccine, mRNA).

Original source: http://www.fda.gov/news-events/press-announcements/fda-brief-fda-hold-advisory-committee-meeting-discuss-pfizer-biontechs-application-covid-19-booster

Related Posts